Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Clinical trial NCT03867201 · COMPLETED
Trial details
- NCT number
- NCT03867201
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2021-08-11
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.